Skip to main content
. 2012 Mar 26;119(20):4608–4613. doi: 10.1182/blood-2011-12-395715

Table 5.

Additional efficacy outcomes (among evaluable patients)

Outcome Median (95% CI)
Time to VGPR + PR, mo 1.6 (1.6-3.5)
PFS, mo 6.1 (3.7-9.4)
OS, mo — (17=—)

VGPR indicates very good partial remission; PR, partial remission; PFS, progression free survival; OS, overall survival; and —, not reached yet.